WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
GENEVA, May 25 (Reuters) – The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was […]
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns Read Post »
